MOVE

Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.

Wall Street analysts forecast MOVE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MOVE is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Movano Inc revenue for the last quarter amounts to 80.00K USD, increased 60.00 % YoY.

Movano Inc. EPS for the last quarter amounts to -47.34 USD, increased 348.30 % YoY.

Movano Inc (MOVE) has 32 emplpoyees as of December 15 2025.

Today MOVE has the market capitalization of 7.86M USD.